Number of pages: 100 | Report Format: PDF | Published date: March 02, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
Report Attribute |
Details |
Market Size Value in 2022 |
US$ 1.8 billion |
Revenue Forecast in 2031 |
US$ 5.27 billion |
CAGR |
12.7% |
Base Year for Estimation |
2022 |
Forecast Period |
2023-2031 |
Historical Year |
2021 |
Segments Covered |
Product, Application, and Region |
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global sacral nerve stimulation devices market was valued at US$ 1.8 billion in 2022 and is expected to register a revenue CAGR of 12.7% to reach US$ 5.27 billion by 2031.
Sacral Nerve Stimulation Devices Market Fundamentals
Sacral nerve stimulation (SNS) is a medical treatment involving the implantation of a device that delivers electrical impulses to the sacral nerves near the bottom of the spinal cord. The sacral nerves play a critical role in controlling the function of the bladder, bowel, and pelvic floor muscles. SNS treats conditions, such as urinary and fecal incontinence (FI), urinary retention, and pelvic pain that have not responded to other treatments. The device, similar to a pacemaker, is implanted under the skin in the buttock and connected to a lead placed near the sacral nerves. The electrical impulses delivered by the device can help regulate the activity of the bladder, bowel, and pelvic floor muscles, improving their function and reducing symptoms. The market for sacral nerve stimulation devices includes a variety of devices, including implantable pulse generators, lead wires, and external controllers.
SNS device is a stopwatch-sized neuromodulator that stimulates the nerves using mild or moderate electrical impulses. SNS is an effective treatment to overcome the negative effects of anticholinergic medications. These devices force the external sphincter and pelvic floor muscle to tighten, which inhibits bladder contraction that results in the unintentional release of urine. According to research, the c-afferent fibers that make up the afferent limb of the pathogenic reflex arc causing incontinence are blocked by sacral neuromodulation (SNM). The market is expected to grow significantly due to an increase in awareness about SNS therapy, growth in healthcare expenditure, and a rise in the aging population.
However, the market revenue growth may be hindered by factors such as the high cost of devices and the lack of reimbursement policies in certain regions.
Overall, the sacral nerve stimulation devices market presents opportunities for both established and new players in the industry, driven by the increasing demand for minimally invasive procedures and the growing awareness among patients about the benefits of SNS therapy.
[78667567]
Sacral Nerve Stimulation Devices Market Dynamics
The sacral nerve stimulation devices market is fueled by the increase in the prevalence of sacral nerve problems and the rise in demand for sacral nervous stimulation devices to overcome the negative side effects of drugs. The market is also supported by the rising demand for minimally invasive procedures and increasing patient awareness about the benefits of SNS therapy. Additionally, the rising geriatric population with incontinence issues, unhealthy eating habits, and the rising number of patients with urinary tract infections (UTI) that cause symptoms of overactive bladder (OAB) is also a key factor propelling the revenue growth of the global market. The higher failure rate of physical therapy, lifestyle modifications, and medications via drugs are increasing the demand for SNS devices. Moreover, the adoption of advanced technologies, such as radiofrequency technology, in SNS devices is also boosting market revenue growth. Similarly, a rise in the focus of major medical technology manufacturers on product launches with long-term efficacy in treating OAB is also expected to drive revenue growth in the global market.
However, side effects associated with the usage of SNS devices, such as wound infection, bruising, UTI, pain over the wound site, difficulty in passing urine, change to bowel function, movement of the electrodes (dislodged or broken), and device malfunction (technical issues/battery failure), are restricting the global market revenue growth. Moreover, poor reimbursement policies are also cramping the revenue growth of the global market.
Sacral Nerve Stimulation Devices Market Ecosystem
The global sacral nerve stimulation devices market has been analyzed from three perspectives: product, application, and region.
Sacral Nerve Stimulation Devices Market by Product
[865757]
Based on the product, the global sacral nerve stimulation devices market is segmented into external SNS devices and implantable SNS devices.
The implantable SNS devices accounted for the largest revenue share of the global sacral nerve stimulation devices market in 2022. The large revenue share of the implantable SNS devices segment can be attributed to the increasing prevalence of OAB and the growing awareness of benefits associated with the devices, such that they are reversible treatment options and can be discontinued anytime. The implantable SNS devices procedure is minimally invasive, thus fueling the demand for implantable SNS devices. Moreover, the increasing prevalence of urinary incontinence, FI, and urinary retention is expected to propel revenue growth in the segment.
Sacral Nerve Stimulation Devices Market by Application
Based on application, the global sacral nerve stimulation devices market is segmented into urinary incontinence, fecal incontinence, and others.
The urinary incontinence segment dominated the global sacral nerve stimulation devices market with the largest revenue share in 2022. The large share of the urinary incontinence segment can be attributed to the increasing number of elderly people with urine incontinence and the rising prevalence of male prostate gland issues, including prostate cancer and enlarged prostate. Moreover, menopause in women lowers estrogen production, which has been linked to the aggravation of incontinence, boosting segment revenue growth. Similarly, the rise in adoption of unhealthy lifestyles, obese population, and history of hysterectomies and stroke are also expected to propel the segment revenue growth.
Sacral Nerve Stimulation Devices Market by Region
Based on the region, the global sacral nerve stimulation devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
North America dominated the global sacral nerve stimulation devices market in 2022, primarily due to the region’s high prevalence of urinary and FI, a large aging population, and a well-established healthcare infrastructure. The United States is the largest market for sacral nerve stimulation devices in North America.
The Asia Pacific market is anticipated to grow at the fastest revenue CAGR during the forecast period. Moreover, the growing prevalence of lifestyle diseases and high life expectancy contributing to a large geriatric population are also pivotal in regional market development. A rise in the adoption of breakthrough medical technologies and an increase in investment in research and development related to SNS devices are propelling revenue growth in the regional market. Similarly, the presence of major market players is also expected to boost regional growth.
Sacral Nerve Stimulation Devices Market Competitive Landscape
The prominent companies operating in the global sacral nerve stimulation devices market include:
Sacral Nerve Stimulation Devices Market Strategic Developments
The rise in the geriatric population, the increase in the adoption of nervous stimulation devices to overcome the negative side effects of drugs, and the increase in cases of sacral nerve problems are driving revenue growth in the global market. Moreover, the rising number of patients with urinary tract infections (UTI) and the increasing product launches are driving revenue growth in the global market.
North America accounts for the largest market revenue share, followed by Europe, and Asia Pacific is expected to be the fastest-growing region during the forecast period.
The side effect associated with SNS devices and poor reimbursement policies are restricting revenue growth in the global market.
Medtronic Plc., Laborie Medical Technologies Inc., Abbott Laboratories Inc., Axionics Modulation Technologies Inc., and Nuvectra are among the top market players.
The global sacral nerve stimulation devices market is expected to grow at a revenue CAGR of 12.7% and reach 5.27 billion by 2031.
*Insights on financial performance are subject to the availability of information in the public domain